Improvement of a synthetic live bacterial therapeutic for phenylketonuria with biosensor-enabled enzyme engineering

In phenylketonuria (PKU) patients, a genetic defect in the enzyme phenylalanine hydroxylase (PAH) leads to elevated systemic phenylalanine (Phe), which can result in severe neurological impairment. As a treatment for PKU, Escherichia coli Nissle (EcN) strain SYNB1618 was developed under Synlogic’s S...

Descripción completa

Detalles Bibliográficos
Autores principales: Adolfsen, Kristin J., Callihan, Isolde, Monahan, Catherine E., Greisen, Per Jr., Spoonamore, James, Momin, Munira, Fitch, Lauren E., Castillo, Mary Joan, Weng, Lindong, Renaud, Lauren, Weile, Carl J., Konieczka, Jay H., Mirabella, Teodelinda, Abin-Fuentes, Andres, Lawrence, Adam G., Isabella, Vincent M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553829/
https://www.ncbi.nlm.nih.gov/pubmed/34711827
http://dx.doi.org/10.1038/s41467-021-26524-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8553829/
https://www.ncbi.nlm.nih.gov/pubmed/34711827
http://dx.doi.org/10.1038/s41467-021-26524-0

Ejemplares similares